Catheter closure for patent ductus arteriosus in children
Part of Genetic & congenital, Heart & circulation clinical trials.
This study looks at how well a procedure called transcatheter closure works for children with Patent Ductus Arteriosus (PDA), a small extra blood vessel in the heart that should close after birth. The procedure uses a thin tube (catheter) to close the vessel without open surgery, and researchers want to see how children do over a 3-year period.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Ages 6 months to 16 years
- Has a heart condition called Patent Ductus Arteriosus (PDA), confirmed by an echocardiogram
- Is eligible for a catheter-based closure procedure (no open surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a procedure that closes a small heart tube (called the ductus arteriosus) that stays open after birth. The goal is to see if closing it helps the heart work better in teens and adults.
This trial creates a registry to gather information on premature babies who have a PDA (an open blood vessel in the heart) and are getting it closed with a catheter-based device. It helps doctors learn more about how safe and effective this treatment is for these tiny babies.
This study checks how well and how safely the Occlutech PDA Occluder works over time to close a patent ductus arteriosus (PDA). You may be considered if your PDA can be treated with this non-surgical device and you can return for follow-up visits.
This trial compares an early procedure to close a heart vessel called the ductus arteriosus versus careful observation alone in very low-birth-weight preterm infants. It aims to see whether closing the vessel early can improve outcomes and be done safely.
This study looks at how children and teens recover after closing a common heart hole (ventricular septal defect) using a special device placed through a tube. It aims to see if the closure works well and how the heart does over time.
This study tests a personalized approach to treating a common heart condition in very early preterm babies, where a blood vessel (the ductus arteriosus) stays open. It aims to find the best time and way to close this vessel using medication, based on the baby's specific biomarkers.
Hear when a new Patent Ductus Arteriosus (PDA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.